Swapcard

Welcome to your DIA Community!

Exhibitors

The DIA Oligonucleotide-Based Therapeutics Conference brings together leading experts to inform, educate, and share advancements in oligonucleotide-based therapeutic product development. Developed collaboratively by regulators, industry professionals, and academics, the program covers a wide range of topics from the nonclinical, CMC, and clinical areas, including emerging CMC guidances and considerations, learnings from recent regulatory filings, extra-hepatic and CNS delivery of oligonucleotides, toxicology testing, gene editing, and safety assessments. The conference offers a unique three-day experience with multiple perspectives presented and the opportunity to interface with regulators from around the globe.